Raisa Howard CNP

Womens Clinic Los Angeles

We're glad to help.

Every year more women choose to use Mifeprex, a Non-surgical abortion pill to terminate a pregnancy. One of the reasons is to avoid the potential risk of a surgical procedure like uterine perforation, scarring or infection .There is also a consideration of other risks of general anesthesia.

Mifeprex Abortion Pill or RU 486 is administered orally, followed by administration of Cytotec which can be inserted orally or vaginally to induce contractions resulting in spontaneous evacuating products of conception

It is expected to have moderate to severe discomfort or cramps few hours after administering Cytotec. Usually the expulsion of the tissue occurs in about 6 to 24 hours. The bleeding is expected to be moderate and last for up to 3 weeks off and on.

Any bleeding in access of 1 pad completely saturated with blood within an hour should be evaluated. About 5% of women using Mifeprex to terminate an early pregnancy will require a surgical evacuation due to failure of the method or retained tissue or blood clots.

Serious side effects to Mifeprex use for an abortion of early pregnancy are rare. They include excessive bleeding requiring a blood transfusion and serious infections. More common side effects include cramps, nausea or vomiting, headache, fever, dizziness, fatigue, body aches, chills. They usually do not last more than 24-48 hours. It is important to see a medical provider if severe pain or fever persist over 24 hours.

Contraindications to Mifeprex include presence of an IUD or Mirena IUS, ectopic pregnancy, chronic adrenal problems, severe anemia, allergy to Mofeprex or Cytotec, unavailability of emergency facility or inability to come back for a follow up.

Other medical uses for Mifeprex Abortion Pill in clinical studies include treatment of fibroids, endometriosis, breast cancer, ovarian cancer, glaucoma ,cancer of the prostate, some brain tumors and other diseases.

Mifeprex Early Abortion Pill

Mifeprex or RU 486 is a pharmaceutical compound that is originated in France in 1988 and then in September of 2000 was approved by FDA in United States for abortion of unwanted pregnancy up to 49 days of gestation

It is 92% effective for a termination of an early pregnancy

It is recommended to have a complete GYN exam including STD screening prior to undergoing a non-surgical procedure for a termination of the pregnancy.